On February 2, 2024, the FDA published the final rule for the Quality Management System Regulation (QMSR), replacing the long-standing Quality System Regulation (QSR) under 21 CFR Part 820. This update incorporates ISO 13485:2016 as the new foundation for medical device quality management systems, introducing significant changes for manufacturers, especially those not previously aligned with ISO 13485. For a deeper dive into this, click here.
In this video, Mike Wolf, CMDA, CQA, RAC (Director of Client Services at Theoris), explains the core updates, which requirements remain from the QSR, and practical steps to prepare for the February 2, 2026 compliance date.
The FDA’s QMSR is designed to harmonize U.S. quality management requirements with internationally recognized standards. By incorporating ISO 13485:2016, the FDA aims to reduce compliance burdens for manufacturers operating globally while maintaining device safety and effectiveness.
While many requirements will feel familiar, QMSR introduces or emphasizes several elements:
Even ISO 13485-certified companies must address QMSR’s FDA-specific elements, including:
Our Quality and Compliance Consulting team offers:
We’re also offering a free 30-minute QMSR readiness consultation to discuss your current QMS alignment, resource planning, and priority gaps before the compliance deadline. Contact us here or email info@theoris.com for more information.
Don’t wait! Schedule your free consultation today at https://www.theoris.com/contact/.